NIH Guide: Weekly Index for August 25, 2023

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
  (PA-23-263)
  National Institutes of Health
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): September 7, 2025
• AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18)
  (PA-23-290)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): August 31, 2028
• AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01)
  (PA-23-291)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): August 31, 2028
• Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
  (PAR-23-274)
  National Institute on Aging
  Application Receipt Date(s): November 21, 2024
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
  (PAR-23-279)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2024
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  (PAR-23-280)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2024
• Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
  (PAR-24-027)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 30, 2026
• Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-AG-24-027)
  National Institute on Aging
  Application Receipt Date(s): February 14, 2024
• Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)
  (RFA-AG-24-046)
  National Institute on Aging
  Application Receipt Date(s): February 7, 2024
• The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
  (RFA-CA-23-042)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required)
  (RFA-CA-24-007)
  National Cancer Institute
  Application Receipt Date(s): Not Applicable
• HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed)
  (RFA-DA-24-068)
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): October 30, 2023
• HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Coordination and Translation Center (U2C Clinical Trial Optional)
  (RFA-DA-24-069)
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): October 30, 2023
• Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
  (RFA-DA-25-018)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional)
  (RFA-MH-24-160)
  National Institute of Mental Health
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Office of AIDS Research
  Application Receipt Date(s): Not Applicable
• Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
  (RFA-MH-24-161)
  National Institute of Mental Health
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Office of AIDS Research
  Application Receipt Date(s): Not Applicable
• Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
  (RFA-MH-24-162)
  National Institute of Mental Health
  Office of Research on Women's Health
  Office of AIDS Research
  Application Receipt Date(s): Not Applicable
• Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional)
  (RFA-RM-23-012)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): October 31, 2023